Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01479673
Other study ID # 4329
Secondary ID
Status Recruiting
Phase N/A
First received November 22, 2011
Last updated November 21, 2013
Start date November 2011
Est. completion date December 2014

Study information

Verified date November 2013
Source Rabin Medical Center
Contact Pierre Singer, MD,Professor
Phone 972-3-9376521
Email psinger@clalit.org.il
Is FDA regulated No
Health authority Israel: Ethics Commission
Study type Interventional

Clinical Trial Summary

The aim of this study is to perform a prospective, randomized, controlled blinded study in critically patients to assess the necessity for measuring daily resting energy expenditure as a guide for nutritional support. Our hypothesis is that tight caloric control will reduce the rate of new infections.

Study Design :Multi-center, randomized, single blinded, controlled study. Study Population: newly-admitted, adult mechanically ventilated ICU patients.


Description:

Study objectives

To evaluate the effect of tight caloric control in critical patients on:

- The rate of acquired nosocomial infections (Ventilated associated pneumonia, Catheter related infections, Urinary tract infections)

- Mortality rates, length of stay in the ICU and in hospital, length of ventilation and incidence of non-infectious complications.

Primary endpoint:

Rate of nosocomial infections (for definitions see appendage 1) acquired after 48 to 72 hours following admission.

Secondary endpoints

- Metabolic control: glucose concentration, insulin administration, rate of hypoglycemic events.

- Success of tight caloric control: accumulative and maximum negative energy balance.

- Organ function: SOFA score.

- Rate of non-infectious complications: requirement for surgery or occurrence of pressure sores.

- Length of ICU stay and of assisted ventilation (LOS and LOV)

- ICU survival rate.

- Patient status and disposition on day 28 or at hospital discharge.

- 3 & 6 months survival.


Recruitment information / eligibility

Status Recruiting
Enrollment 560
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Mechanically-ventilated adults(Male or Female)admitted to general ICU within the first 48 hours of ICU admission.

2. Age = 18 years;no upper age limit.

3. Expected stay in ICU> 3 days: [SAPS II (18) > ICU median or high-level of nursing care implemented or per clinical impression of attending physician]

4. Medical and abdomino/thoracic surgery patients, as well as multiple trauma patients with Glasgow Coma Score = 10.

Exclusion Criteria:

1. Pregnancy.

2. DNR order.

3. Readmission in the ICU during the same hospitalization/transfer from other ICU.

4. Admission for postoperative monitoring.

5. Respiratory instability: SpO2 <90% or need for ventilator adjustments during the preceding hour or hyperventilation (Respiratory rate > 35/min)

6. Bicarbonate infusion, loss of bicarbonate (diarrhea, ureterosogmoidostomy or use of acetazoloamide, ultrafiltration).

7. Aerosolization with nitric oxide or heliox, tracheal insufflations or visible leaks in chest drainage system.

8. FiO2 80% or patients requiring prone position

9. Chronic/acute liver failure:Child-Pugh class C

10. Brain injury for various reasons with Glasgow Coma Scale below 10.

11. Cardiac surgery patients.

12. Patients in the hospital for more than 7 days.

13. Contra indication to use enteral nutrition.

14. Participation in a clinical study with an investigational drug within one month prior to the start of this clinical trial.

15. Ethical issues that will influence subject eligibility.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Diagnostic


Related Conditions & MeSH terms

  • Mechanical Ventilation Complication

Intervention

Dietary Supplement:
Indirect Calorimetry measurement of Resting Energy Expenditure .
Patients in this group will receive enteral nutrition/parenteral nutrition or combination of enteral and parenteral nutrition according to the individual energy requirements calculated by Indirect Calorimetry.

Locations

Country Name City State
Israel Rabin Medical Center, Campus Beilinson Petach Tikva

Sponsors (2)

Lead Sponsor Collaborator
Rabin Medical Center Baxter Healthcare Corporation

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of nosocomial infections Rate of nosocomial infections acquired after 48 to 72 hours following admission up to day 28/or discharge will be evaluated After 48 to 72 hours /daily assessment: within 28 day No
Secondary Metabolic control Glucose concentration, insulin administration, rate of hypoglycemic events will be daily assessed Day 1 up to day 28/or discharge No
Secondary Caloric control Success of tight caloric control:accumulative and maximum negative energy balance Day 1 up to day 28/or discharge No
See also
  Status Clinical Trial Phase
Recruiting NCT05030337 - Optimising Ventilation in Preterms With Closed-loop Oxygen Control N/A
Completed NCT05144607 - Impact of Inspiratory Muscle Pressure Curves on the Ability of Professionals to Identify Patient-ventilator Asynchronies N/A
Recruiting NCT03697785 - Weaning Algorithm for Mechanical VEntilation N/A
Completed NCT05084976 - Parental Perception of COVID-19 Vaccine in Technology Dependent Patients
Active, not recruiting NCT05886387 - a Bayesian Analysis of Three Randomised Clinical Trials of Intraoperative Ventilation
Completed NCT04429399 - Lowering PEEP: Weaning From High PEEP Setting N/A
Completed NCT02249039 - Intravenous Clonidine for Sedation in Infants and Children Who Are Mechanically Ventilated - Dosing Finding Study Phase 1
Recruiting NCT02071524 - Evaluation of the Effects of Fluid Therapy on Respiratory Mechanics N/A
Completed NCT01114022 - Prevention Inhalation of Bacterial by Using Endotracheal Tube Balloon Polyvinyl Chloride or Polyurethane N/A
Completed NCT00893763 - Strategies To Prevent Pneumonia 2 (SToPP2) Phase 2
Terminated NCT05056103 - Automated Secretion Removal in ICU Patients N/A
Active, not recruiting NCT04558476 - Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation Phase 2
Recruiting NCT05295186 - PAV Trial During SBT Trial
Active, not recruiting NCT05370248 - The Effect of 6 ml/kg vs 10 ml/kg Tidal Volume on Diaphragm Dysfunction in Critically Mechanically Ventilated Patient N/A
Completed NCT04818164 - Prone Position Improves End-Expiratory Lung Volumes in COVID-19 Acute Respiratory Distress Syndrome
Completed NCT04589910 - Measuring Thickness of the Normal Diaphragm in Children Via Ultrasound. N/A
Completed NCT04193254 - LPP , MP and DP:Relation With Mortality and SOFA in Mechanically Ventilated Patients in ER, Ward and ICU
Not yet recruiting NCT03259854 - Non Invasive Mechanical Ventilation VERSUS Oxygen MASK N/A
Not yet recruiting NCT03245684 - Assisted or Controlled Ventilation in Ards (Ascovent) N/A
Completed NCT06332768 - NIV Versus HFO Versus Standard Therapy Immediately After Weaning From Mechanical Ventilation in ARDS Patients N/A